Petralia Giuseppe, Padhani Anwar R
Department of Radiology, IEO - European Institute of Oncology IRCCS, Via Ripamonti, 435, Milan 20141, Italy; Department of Oncology and Hematology, University of Milan, Via Festa del Perdono 7, Milan 20122, Italy.
MR unit, Paul Strickland Scanner Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):495-507. doi: 10.1016/j.mric.2018.06.003.
Whole-body MRI (WB-MRI) has emerged as a radiation-free method for the diagnosis, staging, and therapy response assessments in cancer patients. This article reviews the current roles for WB-MRI in the clinical context of limitations of currently used techniques, focusing on bone marrow disease applications. Indication for broader clinical use are discussed, including guideline recommendations. The emerging screening role of WB-MRI in subjects at high risk of cancer is discussed, as is normal population screening.
全身磁共振成像（WB-MRI）已成为一种用于癌症患者诊断、分期及治疗反应评估的无辐射方法。本文回顾了WB-MRI在当前技术局限性的临床背景下的现有作用，重点关注骨髓疾病的应用。文中讨论了其更广泛临床应用的适应症，包括指南建议。还讨论了WB-MRI在癌症高危人群中新兴的筛查作用以及在普通人群中的筛查情况。
